CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Shire and Prometheus Laboratories, Inc.
Target Audience: The intended audience for this activity is gastroenterologists, pediatric gastroenterologists, internal medicine physicians, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with inflammatory bowel disease (IBD).
Learning Objectives: Upon successful completion of this activity, participants should be better able to:
- Differentially diagnose inflammatory bowel disease using current classification criteria as well as diagnostic modalities, such as serologic, genetic, and inflammation markers.
- Develop treatment strategies that achieve long-term remission and minimize risk of relapse in Crohn’s disease and ulcerative colitis.
- Implement strategies for monitoring disease activity and mucosal healing in accordance with the most current definitions in patients with inflammatory bowel disease.
- Implement individualized therapy by using evidence-based prognostic tools and serological markers to predict disease course in inflammatory bowel disease.
- Summarize recent therapeutic advances for ulcerative colitis and Crohn’s disease and their potential implications for the future treatment of inflammatory bowel disease.
Activity Chair:
Gary R. Lichtenstein, MD
Professor of Medicine
Raymond and Ruth Perelman School of Medicine of the University of Pennsylvania
Director, Center for Inflammatory Bowel Disease
Department of Medicine
Division of Gastroenterology
Philadelphia, PA
Faculty:
William J. Sandborn, MD
Professor of Medicine and Adjunct Professor of Surgery
Chief
Division of Gastroenterology
Director
UCSD IBD Center
University of California San Diego and UC San Diego Health System
La Jolla, CA
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
For the purpose of recertifying with ANCC, AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME can be used.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 0.50 hours credit for completing this program.
This enduring material was originally approved for 1 year from the date of original release, December 22, 2015, to December 21, 2016. It has since been recertified for two additional years and will now expire on December 9, 2018.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME Content, complete the CME posttest, and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 2 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Planning Committee and Faculty:
Gary R. Lichtenstein, MD, FACP, FACG, AGAF
William J. Sandborn, MD
Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 11/25/2017)
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.
Planning committee and Faculty Members reports the following relationship(s) which are relevant at the time of original content release (December 22, 2015):
Gary R. Lichtenstein, MD
Royalty: SLACK, Inc.
Consulting Fee: Abbott /Abbvie, Activis, Alaven, Ferring, Hospira, Janssen Orthobiotech, Luitpold/American Regent, Pfizer, Prometheus, Salix, Santarus, Shire, Takeda, UCB, Warner Chilcotte
Contracted Research: Ferring, Janssen Orthobiotech, Prometheus, Salix, Santarus, Shire, UCB, Warner Chilcott
Research Grant (paid to institution): Janssen Orthobiotech, Warner Chilcott
Author Honoraria: McMahon Publishing, Up-to-Date
Editor Honoraria: Advances in Gastroenterology, Gastro-Hep Communications, Springer Science and Business Media
William J. Sandborn, MD
Consulting Fee: AbbVie, Actavis, Amgen, Genentech, Janssen, Pfizer, Prometheus Laboratories, Receptos, Salix, Santarus, Shire, Takeda, UCB Pharma
Speakers Bureau: Takeda
Contracted Research: AbbVie, Amgen, Genentech, Janssen, Pfizer, Prometheus Laboratories, Receptos, Takeda
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com.